Table 3. Assessment of dysglycemia and T2DM based on AUC and optimal cut-off points for HOMA-IR.
Men | Women | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
AUC (95% CI) | Cut-off | Sensitivity, % | Specificity, % | PPV, % | NPV, % | AUC (95% CI) | Cut-off | Sensitivity, % | Specificity, % | PPV, % | NPV, % | |
Dysglycemia | 0.685 (0.671–0.719) | 1.6 | 64.3 | 64.5 | 65.0 | 63.6 | 0.728 (0.708–0.748) | 1.6 | 63.3 | 70.0 | 58.6 | 73.5 |
T2DM | 0.774 (0.730–0.818) | 2.9 | 56.7 | 85.4 | 21.2 | 96.6 | 0.837 (0.794–0.879) | 2.4 | 72.6 | 79.9 | 12.8 | 98.6 |
T2DM, type 2 diabetes mellitus; AUC, area under the curve; HOMA-IR, homeostasis model assessment of insulin resistance; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value.